chloroquine has been researched along with GS-441524 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreca, ML; Cecchetti, V; Cernicchi, G; Corona, A; De Jonghe, S; Esposito, F; Felicetti, T; Jochmans, D; Manfroni, G; Massari, S; Milia, J; Neyts, J; Nizi, MG; Persoons, L; Sabatini, S; Schols, D; Tabarrini, O; Tramontano, E; Vangeel, L | 1 |
| Brügel, M; Habler, K; Liebchen, U; Paal, M; Scharf, C; Schönermarck, U; Teupser, D; Vogeser, M | 1 |
2 other study(ies) available for chloroquine and GS-441524
| Article | Year |
|---|---|
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity.
Topics: | 2022 |
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum
Topics: Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Chloroquine; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Furans; Humans; Hydroxychloroquine; Isotopes; Lopinavir; Pandemics; Pyrazines; Pyrroles; Ritonavir; SARS-CoV-2; Tandem Mass Spectrometry; Triazines | 2021 |